SI1656372T1 - 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases - Google Patents

2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases

Info

Publication number
SI1656372T1
SI1656372T1 SI200432053T SI200432053T SI1656372T1 SI 1656372 T1 SI1656372 T1 SI 1656372T1 SI 200432053 T SI200432053 T SI 200432053T SI 200432053 T SI200432053 T SI 200432053T SI 1656372 T1 SI1656372 T1 SI 1656372T1
Authority
SI
Slovenia
Prior art keywords
prevention
treatment
autoimmune diseases
pyrimidinediamine compounds
pyrimidinediamine
Prior art date
Application number
SI200432053T
Other languages
Slovenian (sl)
Inventor
Singh Rajinder
Argade Ankush
Hui Li
Somasekhar Bhamidipati
David Carroll
Catherine Sylvain
Jeffrey Clough
Holger Keim
Original Assignee
Rigel Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals, Inc. filed Critical Rigel Pharmaceuticals, Inc.
Priority claimed from PCT/US2004/024716 external-priority patent/WO2005016893A2/en
Publication of SI1656372T1 publication Critical patent/SI1656372T1/en

Links

SI200432053T 2003-07-30 2004-07-30 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases SI1656372T1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US49164103P 2003-07-30 2003-07-30
US53159803P 2003-12-19 2003-12-19
US57224604P 2004-05-18 2004-05-18
PCT/US2004/024716 WO2005016893A2 (en) 2003-07-30 2004-07-30 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
EP04786150.5A EP1656372B1 (en) 2003-07-30 2004-07-30 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases

Publications (1)

Publication Number Publication Date
SI1656372T1 true SI1656372T1 (en) 2013-08-30

Family

ID=49078154

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200432053T SI1656372T1 (en) 2003-07-30 2004-07-30 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases

Country Status (1)

Country Link
SI (1) SI1656372T1 (en)

Similar Documents

Publication Publication Date Title
HRP20130602T1 (en) 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
WO2004006858A3 (en) Compounds, compositions, and methods employing same
HK1091732A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
IL174637A0 (en) Fibrosis-inducing agents, compositions containing the same and medical implants containing the same
IL173439A0 (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
IL196301A0 (en) Medicament for the treatment of hapatitis c
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
EP1680145A4 (en) Methods and compositions for the treatment of neurological disease
MXPA03003741A (en) Methods and compositions for the treatment of diseases of the eye.
ZA200307475B (en) Carbamate compounds for use in the treatment of pain.
GB0213869D0 (en) The treatment of pain
EG24959A (en) Indoles useful in the treatment of androgenreceptor related diseases.
AU2003303217A8 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
AU2003255843A1 (en) 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
EP1637162A4 (en) MEDICINAL COMPOSITION FOR PREVENTING OR TREATING Th1 TYPE IMMUNOLOGICAL DISEASE
GB0300428D0 (en) Medical treatment
GB0201025D0 (en) The treatment of degenerative diseases
SI1656372T1 (en) 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
GB2401044B (en) A composition for use in the treatment or prophylaxis of a skin condition in a subject
WO2005023288A8 (en) Treatment of fibrotic disease
GB0327493D0 (en) Treatment medicament
SI1534286T1 (en) Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
AU2003264195A1 (en) Use of guanosine or inosine as anti-apoptotic agents in the treatment of i. a. neurodegenerative diseases or injuries at the nervous system
AU2003217432A8 (en) Angiopoietin-1 in the treatment of disease
IL174968A0 (en) The use of ifenprodil in the treatment of pain